Responsible for overseeing and leading excellence and innovation in Agency science and providing corporate leadership on science-policy issues.
Current research and/or projects
Dr. Michel is responsible for overseeing the Public Health Agency of Canada’s science and research, encompassing: implementing, leading, promoting, and supporting the overall scientific agenda, leading the establishment and monitoring of Agency’s science priorities, promoting Agency science and science partnerships, leveraging funds for science in support of Agency and Ministerial priorities and leading excellence and innovation in Agency science and science-policy integration activities.
Research and/or project statements
- Holds various cross-appointments with the academia and developed collaborations across Canada and internationally, providing epidemiological expertise to multiple major research initiatives.
Recognized expert in the application of public health geomatics and spatial analyses to population-based research.
Interest in the application of modeling, epidemiological methods and decision analysis in assessing priority public health risks arising from the interactions of human populations with animals and the environment.
Professional activities / interests
- Public health lead on a United Nations action team on improving public health through the application of space technologies to improve global health outcomes.
Education and awards
PhD Epidemiology, University of Guelph, 1997
MPVM Preventative Veterinary Medicine, University of California, 1992
DVM Veterinary Medicine, University of Montreal, 1987
International experience and/or work
Rocheleau, J.P., Michel, P., Lindsay, L.R., (...), Fortin, A., Arsenault, J. Risk factors associated with seropositivity to California serogroup viruses in humans and pet dogs, Quebec, Canada. 2018 Epidemiology and Infection. 146(9), pp. 1167-1176.
Hongoh, V., Gosselin, P., Michel, P., (...), Campagna, C., Samoura, K. Criteria for the prioritization of public health interventions for climate-sensitive vector-borne diseases in Quebec 2017. PLoS ONE 12(12), e0190049.
Rocheleau, J.P., Michel, P., Lindsay, L.R., (...), Fortin, A., Arsenault, J. Characterizing environmental risk factors for West Nile virus in Quebec, Canada, using clinical data in humans and serology in pet dogs . 2017 Epidemiology and Infection. 145(13), pp. 2797-2807.
Rocheleau, J.P., Michel, P., Lindsay, L.R., (...), Fortin, A., Arsenault, J. Emerging arboviruses in Quebec, Canada: Assessing public health risk by serology in humans, horses and pet dogs. 2017 Epidemiology and Infection. 145(14), pp. 2940-2948.
Rocheleau, J.-P., Arsenault, J., Ogden, N.H., (...), Drebot, M., Michel, P. Characterizing areas of potential human exposure to eastern equine encephalitis virus using serological and clinical data from horses. 2017 Epidemiology and Infection. 145(4), pp. 667-677.
Hongoh, V., Campagna, C., Panic, M., (...), Samoura, K., Michel, P. Assessing interventions to manage West Nile virus using multi-criteria decision analysis with risk scenarios. 2016 PLoS ONE. 11(8), e0160651.
Donnelly, B., Berrang-Ford, L., Labbé, J., (...), Ross, N.A., Michel, P. Plasmodium falciparum malaria parasitaemia among indigenous Batwa and non-indigenous communities of Kanungu district, Uganda. 2016 Malaria Journal.15(1),1299.
Hongoh, V., Michel, P., Gosselin, P., (...), Cissé, H.D., Waaub, J.-P. Multi-stakeholder Decision Aid for Improved Prioritization of the Public Health Impact of Climate Sensitive Infectious Diseases. 2016 International Journal of Environmental Research and Public Health, 13(4), 419.
Mechai, S., Margos, G., Feil, E.J., (...), Michel, P., Ogden, N.H. Evidence for Host-Genotype Associations of Borrelia burgdorferi Sensu Stricto. 2016 PLoS ONE, 11(2),e0149345.
Michel, P., Martin, L.J., Tinga, C.E., (...), Cieben, B., Jamieson, F. Regional, seasonal, and antimicrobial resistance distributions of Salmonella Typhimurium in Canada: A multi-provincial study. 2006 Canadian Journal of Public Health, 97(6), pp. 470-474.